EDIT

Editas Medicine Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Momentum↓ 3/10
Editas Medicine sales and earnings growth
EDIT Growth
Low
  • Revenue Y/Y↓ -24.90%
  • EPS Y/Y↑ 6.30%
  • FCF Y/Y↑ 5.65%
Editas Medicine gross and profit margin trends
EDIT Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -430.80%
  • ROIC↓ -160.90%
Editas Medicine net debt vs free cash flow
EDIT Risk
Great
  • Debt / Equity↑ 5.9
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -167.5

Editas Medicine stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗